| DIA | SEMANA | MÊS | 3 MESES | 6 MESES | 12 MESES | NO ANO |
|---|---|---|---|---|---|---|
| −0,47% | +3,66% | +6,44% | +18,95% | +6,98% | +20,11% | +18,23% |
| DIA | SEMANA | MÊS | 3 MESES | 6 MESES | 12 MESES | NO ANO | |
|---|---|---|---|---|---|---|---|
| PFE | −0,47% | +3,66% | +6,44% | +21,03% | +10,67% | +28,57% | +24,37% |
| IBOV | 0,00% | −1,74% | +10,91% | +18,49% | +4,74% | +43,26% | +27,50% |
| CDI | 0,00% | +0,15% | +0,92% | +3,19% | +6,65% | +14,24% | +11,07% |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under …